Dr. R.W. Mills, Chief Medical Officer for Nationwide Children's Hospital - Toledo, talks about what to know about RSV as kids ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized ...

“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

For RSV, that target is the so-called F protein that helps the virus latch onto human cells. Again there was a hurdle: That protein is a shape-shifter, rearranging its form before and after it ...

Pfizer and GSK’s RSV vaccines were approved by the FDA in May, and the CDC recommended them for seniors 60 years and up on June 29, citing “shared clinical decision-making.” ...